IGC Pharma, Inc. — Investor Relations & Filings
Filings indexed
762
across all filing types
Latest filing
2026-04-20
Regulatory Filings
Country
US
United States of America
Listing
US
IGC
IGC Pharma, Inc. is a clinical-stage biotechnology company focused on developing treatments for Alzheimer's disease. The company leverages artificial intelligence (AI) in its development process. Its lead candidate, IGC-AD1, is being evaluated in a Phase 2 clinical trial for treating agitation in patients with dementia due to Alzheimer's. The company's pipeline also includes TGR-63, a pre-clinical small molecule designed to inhibit amyloid plaque aggregation. Supporting its therapeutic development is MINT-AD, an AI-powered platform for the early detection of Alzheimer's and to improve the understanding of disease progression.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - IGC Pharma, Inc. (0001326205) (Filer) | 2026-04-20 | English | |
| 8-K - IGC Pharma, Inc. (0001326205) (Filer) | 2026-03-30 | English | |
| 10-KT - IGC Pharma, Inc. (0001326205) (Filer) | 2026-03-18 | English | |
| 4 Filing | 2026-02-04 | English | |
| 4 Filing | 2026-01-20 | English | |
| 8-K - IGC PHARMA, INC. (0001326205) (Filer) | 2026-01-06 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 34693717 | 8-K - IGC Pharma, Inc. (0001326205) (Filer) | 2026-04-20 | English | ||
| 33093350 | 8-K - IGC Pharma, Inc. (0001326205) (Filer) | 2026-03-30 | English | ||
| 32979091 | 10-KT - IGC Pharma, Inc. (0001326205) (Filer) | 2026-03-18 | English | ||
| 28898684 | 4 Filing | 2026-02-04 | English | ||
| 28898699 | 4 Filing | 2026-01-20 | English | ||
| 32890161 | 8-K - IGC PHARMA, INC. (0001326205) (Filer) | 2026-01-06 | English | ||
| 11848719 | FORM 8-K | 2026-01-02 | English | ||
|
2025
8 filings
| |||||
| 11848724 | FORM 8-K | 2025-12-15 | English | ||
| 11848723 | Regulatory Filings 2025 | 2025-12-08 | English | ||
| 11848725 | FORM S-3/A | 2025-12-03 | English | ||
| 11848731 | FORM S-3 | 2025-11-14 | English | ||
| 11848732 | FORM S-8 | 2025-11-14 | English | ||
| 11848730 | FORM 10-Q | 2025-11-14 | English | ||
| 11848726 | FORM 8-K | 2025-11-14 | English | ||
| 11848727 | Director's Dealing 2025 | 2025-10-22 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Flydoo Technology Holding Limited
Provides comprehensive travel services, package tours, and …
|
8069 | HK | Professional, scientific and te… |
|
Foghorn Therapeutics Inc.
Develops medicines targeting the chromatin regulatory syste…
|
FHTX | US | Professional, scientific and te… |
|
Formosa Pharmaceuticals, Inc.
Develops ophthalmology and oncology therapies using proprie…
|
6838 | TW | Professional, scientific and te… |
|
Fortrea Holdings Inc.
A global CRO providing clinical development and patient acc…
|
FTRE | US | Professional, scientific and te… |
|
Foxtron Vehicle Technologies Co., Ltd.
Specializes in electric vehicle design, open platforms, and…
|
2258 | TW | Professional, scientific and te… |
|
Frontage Holdings Corporation
Global CRO offering integrated services for drug discovery,…
|
1521 | HK | Professional, scientific and te… |
|
FUNCTIONAL TECHNOLOGIES CORP.
Developed proprietary, advanced yeast-based solutions for t…
|
FEB | CA | Professional, scientific and te… |
|
FUSION ANTIBODIES PLC
CRO providing end-to-end services for preclinical antibody …
|
FAB | GB | Professional, scientific and te… |
|
GEMPHARMATECH CO., LTD.
Provides genetically engineered mouse models and preclinica…
|
688046 | CN | Professional, scientific and te… |
|
Genenta Science S.p.A.
Clinical-stage developer of hematopoietic stem cell gene th…
|
GNTA | IT | Professional, scientific and te… |
IGC Pharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34705/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34705 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34705 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34705 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34705}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IGC Pharma, Inc. (id: 34705)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.